Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

King Appeals Directly To Alpharma Investors To Clear Buyout

This article was originally published in The Pink Sheet Daily

Executive Summary

New offer gives Alpharma a “go-shop” option to find a better price elsewhere.

You may also be interested in...



King’s Dogged Pursuit of Alpharma Comes Up Aces

The combined specialty pharma company to be a leader in abuse-resistant pain meds.

King’s Dogged Pursuit of Alpharma Comes Up Aces

The combined specialty pharma company to be a leader in abuse-resistant pain meds.

King’s Higher Bid For Alpharma Still No Ace, Board Says

"Multiple parties" have indicated interest in a business combination with Alpharma, the company's board of directors said in a letter to shareholders Sept. 26, urging them to reject King's $1.6 billion hostile bid for the company

Related Content

Topics

UsernamePublicRestriction

Register

PS068330

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel